8:25 am: The vaccine from Sanofi and GSK will not be ready before din 2021
French laboratories Sanofi and British GSK announced on Friday that their vaccine against Covid-19 would not be ready until the end of 2021, after less good than expected results from the first clinical trials. The conduct of the program “is being delayed in order to improve the immune response in the elderly,” the groups said in a statement. They initially hoped to apply for licensing in the first half of 2021 and deliver one billion doses that same year.
Sanofi, which is developing this vaccine jointly with GSK – which provides its adjuvant – had recently indicated that it intended to start the very last human trials (so-called “phase 3”) at the end of December.